1. Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study. Issue 5 (May 2018) Authors: Rimassa, Lorenza; Assenat, Eric; Peck-Radosavljevic, Markus; Pracht, Marc; Zagonel, Vittorina; Mathurin, Philippe; Rota Caremoli, Elena; Porta, Camillo; Daniele, Bruno; Bolondi, Luigi; Mazzaferro, Vincenzo; Harris, William; Damjanov, Nevena; Pastorelli, Davide; Reig, María; Knox, Jennifer; Negri,... Journal: Lancet oncology Issue: Volume 19:Issue 5(2018) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial. (April 2014) Authors: Rimassa, Lorenza; Porta, Camillo; Borbath, Ivan; Daniele, Bruno; Finn, Richard S; Raoul, Jean-Luc; Schwartz, Lawrence H; He, Aiwu Ruth; Trojan, Joerg; Peck-Radosavljevic, Markus; Abbadessa, Giovanni; Goldberg, Terri; Santoro, Armando; Bruix, Jordi Journal: Hepatic oncology Issue: Volume 1:Number 2(2014) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tivantinib, a New Option for Second-line Treatment of Advanced Hepatocellular Carcinoma? The Experience of Italian Centers. Issue 2 (March 2015) Authors: Rimassa, Lorenza; Santoro, Armando; Daniele, Bruno; Germano, Domenico; Gasbarrini, Antonio; Salvagni, Stefania; Masi, Gianluca; Abbadessa, Giovanni; Lamar, Maria; Goldberg, Terri; Porta, Camillo Journal: Tumori Issue: Volume 101:Issue 2(2015) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. What about the Circularity of Hazardous Materials?. (21st April 2017) Authors: Goldberg, Terri Journal: Journal of industrial ecology Issue: Volume 21:Number 3(2017:Jun.) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗